Scalar gradient behaviour in MILD combustion

The results of three-dimensional Direct Numerical Simulation (DNS) of Moderate, Intense Low-oxygen Dilution (MILD) and conventional premixed turbulent combustion conducted using a skeletal mechanism including the effects of nonunity Lewis numbers and temperature dependent transport properties are analysed to investigate combustion characteristics using scalar gradient information. The DNS data is also used to synthesise laser induced fluorescence (LIF) signals of OH, CH2O, and CHO. These signals are analysed to verify if they can be used to study turbulent MILD combustion and it has been observed that at least two (OH and CH2O) LIF signals are required since the OH increase across the reaction zone is smaller inMILD combustion compared to premixed combustion. The scalar gradient PDFs conditioned on the reaction rate obtained from the DNS data and synthesised LIF signals suggests a strong gradient in the direction normal to the MILD reaction zone with moderate reaction rate implying flamelet combustion. However, the PDF of the normal gradient is as broad as for the tangential gradient when the reaction rate is high. This suggests a non-flamelet behaviour, which is due to interaction of reaction zones. The analysis of the conditional PDFs for the premixed case confirms the expected behaviour of scalar gradient in flamelet combustion. It has been shown that the LIF signals synthesised using 2D slices of DNS data also provide very similar insights. These results demonstrate that the so-called flameless combustion is not an idealised homogeneous reactive mixture but has common features of conventional combustion while containing distinctive characteristics.The financial supports of Nippon Keidanren, Cambridge Overseas Trust and EPSRC are acknowledged. The direct simulations were made using the facilities of HECToR, the UK’s national high-performance computing service, which is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through EPSRCs High End Computing Programme.This is the accepted manuscript. The final published version is available from Elsevier at http://www.sciencedirect.com/science/article/pii/S0010218013003799

Modelling paradigms for MILD combustion

Three-dimensional Direct Numerical Simulation (DNS) data of methane-air MILD combustion is analysed to study the behaviour of MILD reaction zones and to identify a suitable modelling paradigm for MILD combustion. The combustion kinetics in the DNS was modelled using a skeletal mechanism including non-unity Lewis number effects. The reaction zones under MILD conditions are highly convoluted and contorted resulting in their frequent interactions. This leads to combustion occurring over a large portion of the computational volume and giving an appearance of distributed combustion. Three paradigms, standard flamelets, mild flame elements (MIFEs) and PSR, along with a presumed PDF model are explored to estimate the mean and filtered reaction rate in MILD combustion. A beta function is used to estimate the presumed PDF shape. The variations of species mass fractions and reaction rate with temperature computed using thesemodels are compared to the DNS results. The PSR-based model is found to be appropriate, since the conditional averages obtained from the DNS agree well with those obtained using the PSR model. The flamelets model with MIFEs gives only a qualitative agreement because it does not include the effects of reaction zone interactions.YM acknowledges the financial support of Nippon Keidanren and Cambridge Overseas Trust. EPSRC support is acknowledged by NS. This work made use of the facilities of HECToR, the UK’s national high-performance computing service, which is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through EPSRCs High End Computing Programme.This is the accepted manuscript. The final version is available from Springer at http://link.springer.com/article/10.1007%2Fs12572-014-0106-x

Morphological and statistical features of reaction zones in MILD and premixed combustion

Direct numerical simulation (DNS) results of turbulent MILD premixed and conventional (undiluted) premixed combustion have been investigated to shed light on the physical aspects of reaction zones and their morphology inMILD combustion. Results of a premixed case are used for comparative analyses. The analyses show that the regions with strong chemical activity in MILD combustion are distributed over a substantial portion of the computational domain unlike in the premixed case where these regions are confined to a small portion of the domain. Also, interactions of reaction zones are observed in MILD combustion with their spatial extent increasing with dilution level. These interactions give an appearance of distributed combustion for MILD conditions. The morphology of these reaction zones is investigated using the Minkowski functionals and shapefinders commonly employed in cosmology. Predominant sheet-like structures are observed for the premixed combustion case whereas a pancake-like structure is observed as the most probable shape for the MILD cases. Spatial and statistical analyses of various fluxes involved in a progress variable transport equation are conducted to study autoignitive or propagative characteristics of MILD reaction zones. The results suggest that there are local regions with autoignition, propagating-flames, and their coexistence for the conditions considered in this study. Typically, reaction dominated or ignition front and propagating-flame dominated regions are entangled for high dilution cases. Scalar gradient plays a strong role on whether reaction or propagating-flame dominated activities are favoured locally.YM acknowledges the financial support of Nippon Keidanren and Cambridge Overseas Trust. EPSRC support is acknowledged by NS. This work made use of the facilities of HECToR, the UK’s national high-performance computing service, which is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through EPSRCs High End Computing Programme.This is the accepted manuscript. The final version is available from Elsevier at http://www.sciencedirect.com/science/article/pii/S001021801400128X

DNS of MILD combustion with mixture fraction variations

Direct numerical simulations of Moderate or Intense Low-oxygen Dilution combustion inside a cubical domain are performed. The computational do- main is specified with inflow and outflow boundary conditions in one direction and periodic conditions in the other two directions. The inflowing mixture is constructed carefully in a preprocessing step and has spatially varying mixture fraction and reaction progress variable field. Thus, this mixture in- cludes a range of thermo-chemical state for a given mixture fraction value. The combustion kinetics is modelled using a 58-step skeletal mechanism in- cluding a chemiluminescent species, OH∗, for methane-air combustion. The study of reaction zone structures in the physical and mixture fraction spaces shows the presence of ignition fronts, lean and rich premixed flames and non-premixed combustion. These three modes of combustion are observed without the typical triple-flame structure and this results from the spatio-temporally varying mixture fraction field undergoing turbulent mixing and reaction. The flame index and its pdf are analysed to estimate the fractional contributions from these combustion modes to the total heat release rate. The lean premixed mode is observed to be quite dominant and contribution of non-premixed mode increased from about 11% to 20% when the mean oxygen mole fraction in the inflowing mixture is reduced from about 2.7% to 1.6%. Also, the non-premixed contribution increases if one decreases the integral length scale of the mixture fraction field. All of these results and observations are explained on physical basis.N.A.K.D. acknowledges the financial support of the Qualcomm European Research Studentship Fund in Technology. This work used the ARCHER UK National Supercomputing Service (http://www.archer.ac.uk) using computing time provided by EPSRC under the RAP project number e419 and the UKCTRF (e305). NS acknowledges the support of EPSRC. Y. M. acknowledges the support of JSPS Grant-in-Aid for Young Scientists (B) Grant Number 16K18026

Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial

BACKGROUND Canine inflammatory bowel disease (IBD) is a chronic enteropathy of unknown etiology, although microbiome dysbiosis, genetic susceptibility, and dietary and/or environmental factors are hypothesized to be involved in its pathogenesis. Since some of the current therapies are associated with severe side effects, novel therapeutic modalities are needed. A new oral supplement for long-term management of canine IBD containing chondroitin sulfate (CS) and prebiotics (resistant starch, β-glucans and mannaoligosaccharides) was developed to target intestinal inflammation and oxidative stress, and restore normobiosis, without exhibiting any side effects. This double-blinded, randomized, placebo-controlled trial in dogs with IBD aims to evaluate the effects of 180 days administration of this supplement together with a hydrolyzed diet on clinical signs, intestinal histology, gut microbiota, and serum biomarkers of inflammation and oxidative stress. RESULTS Twenty-seven client-owned biopsy-confirmed IBD dogs were included in the study, switched to the same hydrolyzed diet and classified into one of two groups: supplement and placebo. Initially, there were no significant differences between groups (p > 0.05) for any of the studied parameters. Final data analysis (supplement: n = 9; placebo: n = 10) showed a significant decrease in canine IBD activity index (CIBDAI) score in both groups after treatment (p < 0.001). After treatment, a significant decrease (1.53-fold; p < 0.01) in histologic score was seen only in the supplement group. When groups were compared, the supplement group showed significantly higher serum cholesterol (p < 0.05) and paraoxonase-1 (PON1) levels after 60 days of treatment (p < 0.01), and the placebo group showed significantly reduced serum total antioxidant capacity (TAC) levels after 120 days (p < 0.05). No significant differences were found between groups at any time point for CIBDAI, WSAVA histologic score and fecal microbiota evaluated by PCR-restriction fragment length polymorphism (PCR-RFLP). No side effects were reported in any group. CONCLUSIONS The combined administration of the supplement with hydrolyzed diet over 180 days was safe and induced improvements in selected serum biomarkers, possibly suggesting a reduction in disease activity. This study was likely underpowered, therefore larger studies are warranted in order to demonstrate a supplemental effect to dietary treatment of this supplement on intestinal histology and CIBDAI

Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression

Abstract Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitis, emphysema and irreversible airflow limitation. These changes are thought to be due to oxidative stress and an imbalance of proteases and antiproteases. Quercetin, a plant flavonoid, is a potent antioxidant and anti-inflammatory agent. We hypothesized that quercetin reduces lung inflammation and improves lung function in elastase/lipopolysaccharide (LPS)-exposed mice which show typical features of COPD, including airways inflammation, goblet cell metaplasia, and emphysema. Methods Mice treated with elastase and LPS once a week for 4 weeks were subsequently administered 0.5 mg of quercetin dihydrate or 50% propylene glycol (vehicle) by gavage for 10 days. Lungs were examined for elastance, oxidative stress, inflammation, and matrix metalloproteinase (MMP) activity. Effects of quercetin on MMP transcription and activity were examined in LPS-exposed murine macrophages. Results Quercetin-treated, elastase/LPS-exposed mice showed improved elastic recoil and decreased alveolar chord length compared to vehicle-treated controls. Quercetin-treated mice showed decreased levels of thiobarbituric acid reactive substances, a measure of lipid peroxidation caused by oxidative stress. Quercetin also reduced lung inflammation, goblet cell metaplasia, and mRNA expression of pro-inflammatory cytokines and muc5AC. Quercetin treatment decreased the expression and activity of MMP9 and MMP12 in vivo and in vitro, while increasing expression of the histone deacetylase Sirt-1 and suppressing MMP promoter H4 acetylation. Finally, co-treatment with the Sirt-1 inhibitor sirtinol blocked the effects of quercetin on the lung phenotype. Conclusions Quercetin prevents progression of emphysema in elastase/LPS-treated mice by reducing oxidative stress, lung inflammation and expression of MMP9 and MMP12.http://deepblue.lib.umich.edu/bitstream/2027.42/78260/1/1465-9921-11-131.xmlhttp://deepblue.lib.umich.edu/bitstream/2027.42/78260/2/1465-9921-11-131.pdfPeer Reviewe

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression

Chronic mucosal inflammation is associated with a greater risk of gastric cancer (GC) and, therefore, requires tight control by suppressive counter mechanisms. Gastrokine-2 (GKN2) belongs to a family of secreted proteins expressed within normal gastric mucosal cells. GKN2 expression is frequently lost during GC progression, suggesting an inhibitory role; however, a causal link remains unsubstantiated. Here, we developed Gkn2 knockout and transgenic overexpressing mice to investigate the functional impact of GKN2 loss in GC pathogenesis. In mouse models of GC, decreased GKN2 expression correlated with gastric pathology that paralleled human GC progression. At baseline, Gkn2 knockout mice exhibited defective gastric epithelial differentiation but not malignant progression. Conversely, Gkn2 knockout in the IL-11/STAT3-dependent gp130[superscript F/F] GC model caused tumorigenesis of the proximal stomach. Additionally, gastric immunopathology was accelerated in Helicobacter pylori–infected Gkn2 knockout mice and was associated with augmented T helper cell type 1 (Th1) but not Th17 immunity. Heightened Th1 responses in Gkn2 knockout mice were linked to deregulated mucosal innate immunity and impaired myeloid-derived suppressor cell activation. Finally, transgenic overexpression of human gastrokines (GKNs) attenuated gastric tumor growth in gp130[superscript F/F] mice. Together, these results reveal an antiinflammatory role for GKN2, provide in vivo evidence that links GKN2 loss to GC pathogenesis, and suggest GKN restoration as a strategy to restrain GC progression

Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase

Obliterative bronchiolitis (OB) develops insidiously in nearly half of all lung transplant recipients. Although typically preceded by a CD8+ T cell–rich lymphocytic bronchitis, it remains unresponsive to conventional immunosuppression. Using an airflow permissive model to study the role of gases flowing over the transplanted airway, it is shown that prolonged inhalation of sublethal doses of carbon monoxide (CO), but not nitric oxide (NO), obliterate the appearance of the obstructive airway lesion. Induction of the enzyme responsible for the synthesis of CO, heme oxygenase (Hmox) 1, increased carboxyhemoglobin levels and suppressed lymphocytic bronchitis and airway luminal occlusion after transplantation. In contrast, zinc protoporphyrin IX, a competitive inhibitor of Hmox, increased airway luminal occlusion. Compared with wild-type allografts, expression of inducible NO synthase (iNOS), which promotes the influx of cytoeffector leukocytes and airway graft rejection, was strikingly reduced by either enhanced expression of Hmox-1 or exogenous CO. Hmox-1/CO decreased nuclear factor (NF)-κB binding activity to the iNOS promoter region and iNOS expression. Inhibition of soluble guanylate cyclase did not interfere with the ability of CO to suppress OB, implicating a cyclic guanosine 3′,5′-monophosphate–independent mechanism through which CO suppresses NF-κB, iNOS transcription, and OB. Prolonged CO inhalation represents a new immunosuppresive strategy to prevent OB

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)